Carmell Therapeutics Price Patterns
| CTCXDelisted Stock | 0.20 0.00 0.00% |
Momentum 35
Sell Extended
Oversold | Overbought |
Using Carmell Therapeutics hype-based prediction, you can estimate the value of Carmell Therapeutics from the perspective of Carmell Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Carmell Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Carmell because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Carmell Therapeutics after-hype prediction price | USD 0.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Carmell |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Carmell Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Carmell Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Carmell Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Carmell Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Carmell Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Carmell Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Carmell Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Carmell Therapeutics' historical news coverage. Carmell Therapeutics' after-hype downside and upside margins for the prediction period are 0.20 and 0.20, respectively. We have considered Carmell Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Carmell Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Carmell Therapeutics is based on 3 months time horizon.
Carmell Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Carmell Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Carmell Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Carmell Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 3 Events / Month | 3 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.20 | 0.20 | 0.00 |
|
Carmell Therapeutics Hype Timeline
Carmell Therapeutics is currently traded for 0.20. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Carmell is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Carmell Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.20. About 20.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.91. Some equities with similar Price to Book (P/B) outperform the market in the long run. Carmell Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state and metro area employment, hours, and earnings.Carmell Therapeutics Related Hype Analysis
Having access to credible news sources related to Carmell Therapeutics' direct competition is more important than ever and may enhance your ability to predict Carmell Therapeutics' future price movements. Getting to know how Carmell Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Carmell Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TCDA | Tricida | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ENTO | Entero Therapeutics | (0.23) | 6 per month | 0.00 | (0.01) | 16.86 | (17.06) | 39.61 | |
| TECX | Tectonic Therapeutic | 0.58 | 7 per month | 3.76 | 0.04 | 6.48 | (5.74) | 22.59 | |
| FRTX | Fresh Tracks Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| XBIO | Xenetic Biosciences | 0.06 | 6 per month | 0.00 | (0.18) | 4.76 | (6.84) | 20.89 | |
| NEUP | Neuphoria Therapeutics | (0.04) | 8 per month | 0.00 | (0.04) | 4.27 | (5.46) | 27.99 | |
| BVXV | BiondVax Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KA | Kineta Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NBRVF | Nabriva Therapeutics Plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MODV | ModivCare | (0.26) | 2 per month | 0.00 | (0.04) | 17.86 | (25.86) | 149.82 |
Carmell Therapeutics Additional Predictive Modules
Most predictive techniques to examine Carmell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Carmell using various technical indicators. When you analyze Carmell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Carmell Therapeutics Predictive Indicators
The successful prediction of Carmell Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Carmell Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Carmell Therapeutics based on analysis of Carmell Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Carmell Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Carmell Therapeutics's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state and metro area employment, hours, and earnings. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Carmell Stock
If you are still planning to invest in Carmell Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Carmell Therapeutics' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |